Increased levels of mutagen-induced chromosome breakage in Down syndrome children with malignancy

Cancer Genetics and Cytogenetics

Volumn 99, Issue 2, 1997, Pages 126-128

  Ankathil, Ravindran ^a   Kusumakumary, P ^a   Nair, M Krishnan ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; DNA REPAIR; DOWN SYNDROME; DRUG SENSITIVITY; FEMALE; GENETIC ANALYSIS; GENETIC SUSCEPTIBILITY; HUMAN; INFANT; MALE; MUTAGENICITY; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 0030734677     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(97)00205-7     Document Type: Article

References (24)

1. Levitan M Textbook of Human Genetics. 1988;Oxford University Press, New York.
2. Linet ME The Leukaemias, Epidemiologic Aspects. 1985;Oxford University Press, New York. pp. 96-98.
3. Fong C, Brodeur GM Down syndrome and leukemia; epidemiology, genetics, cytogenetics and mechanisms of leukemogenesis. Cancer Genet Cytogenet. 28:1987;55-76.
4. Robinson RL Down syndrome and leukaemia. Leukaemia. 6:1992;5-7.
5. Hsu TC, Johnson DA, Cherry LM, Ramkissoon D, Schantz SP, Jessup JM, Hinn RJ, Shirley L, Furlong C Sensitivity to genotoxic effects of bleomycin in humans. Possible relationship to environmental carcinogenesis. Int J Cancer. 43:1989;403-409.
6. Pathak S, Hopwood VL, Hughes JI, Jackson GL Identification of colon cancer-predisposed individuals. a cytogenetic analysis Am J Gastroenterol. 86:1991;679-684.
7. Cloos J, Braakhuis BJ, Steen I, Copper MP, deVries N, Nauta JJ, Snow GB Increased mutagen sensitivity in head and neck squamous cell carcinoma patients, particularly those with multiple primary tumours. Int J Cancer. 56:1994;816-819.
8. Ravindran Ankathil, Bhattathiri VN, Francis VJ, Ratheesan K, Jyothish B, Chandini R, Dinesh Roy, Elizabeth Abraham, Krishnan Nair M (1996): Mutagen sensitivity as a predisposing factor in familial oral cancer. Int J Cancer 69:265-267.
9. Hsu TC, Spitz MR, Schantz SP Mutagen sensitivity. a biological marker for cancer susceptibility Cancer Epid Biomar Prev. 1:1991;83-89.
10. Hsu TC Genetic predisposition to cancer with special reference to mutagen sensitivity. In Vitro Cell Dev Biol. 23:1987;591-603.
11. Spitz MR, Fueger JJ, Field NA, Annegers JF, Hsu TC, Newall GR Chromosome sensitivity to bleomycin induced mutagenesis - an independent risk factor for upper aerodigestive tract cancers. Cancer Res. 49:1989;4626-4628.
12. Spitz MR, Bondy ML Genetic susceptibility to cancer. Cancer. 72:1993;991-995.
13. Moorhead PS Nowell PC, Mellmam WJ, Battipps DW, Hangerford DA Chromosome preparations of leucocytes cultured from human peripheral blood. Exp Cell Res. 20:1960;613-616.
14. Knudson AG Jr. Hereditary cancers of man. Cancer Invest. 1:1983;187-193.
15. Knudson AG Jr. Hereditary cancer, oncogene and antioncogenes. Cancer Res. 45:1985;1437-1443.
16. Scholl T, Stein Z, Hansen H Leukaemia and other cancers, anomalies and infections as causes of death in DS in the United States during 1976. Dev Med Child Neurol. 24:1982;817-829.
17. Schantz SP, Spitz MR, Hsu TC Mutagen sensitivity in head and neck cancer patients. a biologic marker for risk of multiple primary malignancies J Natl Cancer Inst. 82:1990;1773-1775.
18. Spitz MR, Fueger JJ, Halabi Set al. Mutagen sensitivity in upper aerodigestive tract cancer. a case control analysis Cancer Epidemiol Biomar Prev. 2:1993;329-333.
19. Ankathil R, Nesy EA, Chandini R, Jyothish B, Jayaprakash Madhavan, Krishnan Nair M (1995): Bleomycin induced chromosome sensitivity - Report of a colon cancer family 14:89-94.
20. Lambert B, Hansson K, Bci TH, Funes-Cravioto F, Lindsten J, Holmberg M, Stransmanis R DNA repair and frequency of x-ray and CIU light induced chromosome aberrations in leukocytes from patients with Down's syndrome. Ann Hum Genet. 39:1976;293-303.
21. Aldenhoff P, Wegner RD, Sperling K Different sensitivity of diploid and trisomic cells from patients with Down syndrome mosaic after treatment with the trifunctional alkylating agent Trenimon. Hum Genet. 56:1980;123-125.
22. O'Brien RL, Poon P, Kline E, Parker JW Susceptibility of chromosomes from patients with Down Syndrome to 7,12, dimethyl benz (α) anthracene-induced aberrations in vitro. Int J Cancer. 8:1971;202-210.
23. Higurashi M, Tamura T, Nakatake T Cytogenetic observations in cultured lymphocytes from patients with Down syndrome and measles. Paediatr Res. 7:1973;582-587.
24. Todaro GJ, Martin GM Increased susceptibility of Down syndrome fibroblasts to transformation by SV40. Proc Soc Exp Biol Med. 124:1967;1232-1236.